1. Home
  2. DRTS vs HFRO Comparison

DRTS vs HFRO Comparison

Compare DRTS & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRTS
  • HFRO
  • Stock Information
  • Founded
  • DRTS 2015
  • HFRO 2000
  • Country
  • DRTS Israel
  • HFRO United States
  • Employees
  • DRTS N/A
  • HFRO N/A
  • Industry
  • DRTS Medical/Dental Instruments
  • HFRO Finance/Investors Services
  • Sector
  • DRTS Health Care
  • HFRO Finance
  • Exchange
  • DRTS Nasdaq
  • HFRO Nasdaq
  • Market Cap
  • DRTS 300.2M
  • HFRO 340.3M
  • IPO Year
  • DRTS N/A
  • HFRO N/A
  • Fundamental
  • Price
  • DRTS $3.65
  • HFRO $6.20
  • Analyst Decision
  • DRTS Strong Buy
  • HFRO
  • Analyst Count
  • DRTS 1
  • HFRO 0
  • Target Price
  • DRTS $9.00
  • HFRO N/A
  • AVG Volume (30 Days)
  • DRTS 67.0K
  • HFRO 179.8K
  • Earning Date
  • DRTS 08-11-2025
  • HFRO 01-01-0001
  • Dividend Yield
  • DRTS N/A
  • HFRO 8.87%
  • EPS Growth
  • DRTS N/A
  • HFRO N/A
  • EPS
  • DRTS N/A
  • HFRO N/A
  • Revenue
  • DRTS N/A
  • HFRO N/A
  • Revenue This Year
  • DRTS N/A
  • HFRO N/A
  • Revenue Next Year
  • DRTS N/A
  • HFRO N/A
  • P/E Ratio
  • DRTS N/A
  • HFRO N/A
  • Revenue Growth
  • DRTS N/A
  • HFRO N/A
  • 52 Week Low
  • DRTS $2.11
  • HFRO $4.24
  • 52 Week High
  • DRTS $4.39
  • HFRO $6.45
  • Technical
  • Relative Strength Index (RSI)
  • DRTS 66.81
  • HFRO 80.40
  • Support Level
  • DRTS $3.35
  • HFRO $6.04
  • Resistance Level
  • DRTS $3.63
  • HFRO $6.23
  • Average True Range (ATR)
  • DRTS 0.15
  • HFRO 0.06
  • MACD
  • DRTS 0.03
  • HFRO -0.02
  • Stochastic Oscillator
  • DRTS 101.56
  • HFRO 86.54

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

About HFRO Highland Opportunities and Income Fund of Beneficial Interest

Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.

Share on Social Networks: